The political landscape in America has shifted significantly over time, impacting various alliances, especially between Corporate America, unions, and Big Pharma. This summary explores how these shifts have influenced political dynamics, particularly concerning the pharmaceutical industry and healthcare programs.
1. Changing Alliances:
Corporations and unions have switched political sides, with traditional leftist institutions now appealing to the right. This shift has been linked to Donald Trump, with some attributing his rise to these changes.
2. Corporate America vs. Blue-Collar Workers:
Companies supporting globalism and migration have alienated blue-collar workers, which has fueled Trump’s takeover of the Republican Party. Democrats, like Sen. Bernie Sanders, acknowledge this issue but others on the left remain unaware and continue to focus on unpopular topics.
3. Big Pharma's Political Position:
Historically supported by Republicans, Big Pharma's recent actions have led to conflict within the party. Issues such as exploitation during the COVID pandemic and pushing for certain medications have created unexpected alliances, notably with Bernie Sanders.
4. 340B Federal Program Targeted:
The advocacy group Building America’s Future, backed by Big Pharma, campaigns against the 340B program, which helps low-income patients afford drugs. They falsely claim it benefits illegal immigrants and minors seeking gender transitions. This program is vital for rural hospitals, particularly in Trump-supporting states like Kentucky.
5. Impact of Opioid Epidemic:
Big Pharma is ironically targeting 340B in regions devastated by the opioid crisis, which they contributed to. They profit from the rising transgender hormone market while claiming to protect minors from such treatments.
Big Pharma is attempting to dismantle 340B to avoid offering discounts, which will harm low-income patients and conservative communities. As they profit from various controversial markets, their actions raise ethical questions about their influence on American healthcare and politics.
No comments:
Post a Comment